Topics

Biomarker may predict if immunotherapy is right choice for colorectal cancer patients

20:00 EDT 1 May 2019 | AAAS

(City of Hope) Foundational research could help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as a first treatment option. 'Immunotherapy is the hot thing, but sometimes traditional chemotherapy can be better. Our study suggests tumor genomics could help doctors decide what kind of treatment will benefit each patient most. Taking this kind of personalized medicine approach, we will be able to provide patients with options that yield better outcomes and are more cost-effective.'

Original Article: Biomarker may predict if immunotherapy is right choice for colorectal cancer patients

NEXT ARTICLE

More From BioPortfolio on "Biomarker may predict if immunotherapy is right choice for colorectal cancer patients"

Quick Search

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...